Form4insider filings, from the source

SEC Form 4 · accession 0001144204-16-094715

Altimmune, Inc. · ALT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Apr 13, 2016
Accepted (ET)
Apr 15, 2016 · 7:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326190

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stock, $0.0001 par value per shareApr 13, 2016M13,233$1.76A190,055D
Common Stock, $0.0001 par value per shareApr 13, 2016S13,233$2.20D176,822D
Common Stock, $0.0001 par value per shareApr 13, 2016M150,000$1.16A326,822D
Common Stock, $0.0001 par value per shareApr 13, 2016S150,000$2.20D176,822D
Common Stock, $0.0001 par value per shareApr 13, 2016M91,121$1.16A267,943D
Common Stock, $0.0001 par value per shareApr 13, 2016S91,121$2.20D176,822D
Common Stock, $0.0001 par value per shareApr 13, 2016M75,000$1.19A251,822D
Common Stock, $0.0001 par value per shareApr 13, 2016S75,000$2.20D176,822D
Common Stock, $0.0001 par value per shareF2holding———10,000ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)$1.76Apr 13, 2016M13,233DSep 30, 2012Sep 30, 2021Common Stock13,2330D
Employee Stock Option (right to buy)F3$1.16Apr 13, 2016M150,000D—Dec 7, 2021Common Stock150,0000D
Employee Stock Option (right to buy)$1.16Apr 13, 2016M91,121DDec 7, 2012Dec 7, 2021Common Stock91,1210D
Employee Stock Option (right to buy)F4$1.19Apr 13, 2016M75,000D—Dec 12, 2022Common Stock75,00075,000D

Explanation of responses